The following is a summary of “ALS Motor Observational Telemedicine Objective Rasch-Built Assessment,” published in the ...

Schertz had backed off his stance that he was finished coaching, but he wasn’t entirely convinced he could continue. He ...

In 2023, Tocvan completed a smaller offsite bulk sample at Pilar which showcased the potential to recover both gold and silver through a variety of methods including heap leach, gravity and agitated ...

A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...

Q4 2024 Earnings Conference Call February 12, 2025 8:30 AM ETCompany ParticipantsTim Power - Head of IRChris Viehbacher ...

Kodiak collected a total of 38 rock samples from prospecting on the MPD Northwest claim block in 2024. The focus was to obtain representative samples from most mineralized targets to confirm grades ...

Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...

Denali Therapeutics' experimental drug for amyotrophic lateral sclerosis (ALS) failed to show efficacy in part of the phase 2/3 HEALEY ALS basket trial, causing a fall in its share price.

Fifteen years after the mass shooting at the University of Alabama in Huntsville, a survivor turns that bloodshed into a ...

Brigham Young University researchers are leading a significant validation study of a blood test designed to detect ...

Ziwig, a French biotech company committed to advancing women's health, announces the fast-track reimbursement of Ziwig ...